Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2010
03/11/2010WO2010025851A1 Thienylamino pyrimidines for use as fungicides
03/11/2010WO2010025850A1 Heterocyclically substituted anilinopyrimidines as fungicides
03/11/2010WO2009158431A3 Pyrimidine derivatives as kinase inhibitors
03/11/2010WO2009156099A8 6-substituted isoquinolines and isoquinolinones
03/11/2010US20100063282 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof
03/11/2010US20100063119 Substituted carbinol compound
03/11/2010US20100063088 Raf Kinase Inhibitors
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063078 Spirocompounds useful as modulators for dopamine d3 receptors
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063065 Thiophene derivatives as ppar agonists i
03/11/2010US20100063045 Novel pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
03/11/2010US20100063041 Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same
03/11/2010US20100062972 Triazole compounds and uses related thereto
03/11/2010US20100058545 Cationic dyes
03/11/2010CA2734500A1 Compounds that modulate intracellular calcium
03/11/2010CA2733533A1 Hedgehog pathway modulators
03/10/2010EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
03/10/2010EP2160387A2 Heteroarylamide pyrimidone compounds
03/10/2010EP2029558B1 Compounds and methods for modulating fxr
03/10/2010EP1896456B1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
03/10/2010EP1807420B1 Trisubstituted thiophenes as progesterone receptor modulators
03/10/2010EP1780209B1 Oxime ester compound and photopolymerization initiator containing such compound
03/10/2010EP1751113B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/09/2010US7674909 Tetrahydroquinoline derivatives and their use as FSH receptor modulators
03/09/2010US7674903 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674828 Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions
03/09/2010US7674823 DNA-PK inhibitors
03/09/2010US7674815 5-chloro-1H-indole-7-carboxylic acid benzofuran-2-ylmethyl-[2-(3,4-dichloro-phenyl)-ethyl]-amide; modulates plasma lipid levels; anticholesterol agents
03/09/2010US7674813 Lowering beta amyloid; Alzheimer's disease; gamma secretase inhibitors; pyrazole, imidazole, pyrrole and 1,2,4-triazole sulfonamides; e.g. 5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674796 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
03/09/2010US7674397 Reactive mesogenic charge transport compounds
03/09/2010CA2537598C Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/09/2010CA2482346C Substituted phenylacetamides and their use as glucokinase activators
03/09/2010CA2421819C Isoquinolinone potassium channel inhibitors
03/09/2010CA2399813C Indol-3-yl derivatives
03/09/2010CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators
03/09/2010CA2329292C A process for the manufacture of sulfonylaminocarbonyl triazolinones and salts thereof under ph controlled conditions
03/09/2010CA2306313C Dipeptide nitriles
03/09/2010CA2140598C Prolineamide derivatives
03/04/2010WO2010025295A2 Compounds that modulate intracellular calcium
03/04/2010WO2010024430A1 2,4-diaminopyrimidine compound
03/04/2010WO2010024227A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
03/04/2010WO2010023688A2 An improved process for the preparation of eprosartan
03/04/2010WO2010004215A3 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof
03/04/2010WO2009010478A3 Use of piperidine derivatives as agonists of chemokine receptor activity
03/04/2010US20100056798 Synthesis of herbicide 5-methoxy-4-methyl-2-[(4-methoxycarbonyl-2-methyl-thien-3-yl)-sulfonylaminocarbonyl]-2,4-dihydro-3H-1,2,4-triazol-3-one or salts aka thiencarbazone-methyl
03/04/2010US20100056758 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
03/04/2010US20100056614 C10 cyclopentyl ester substituted taxanes
03/04/2010US20100056587 Substituted Aminothiazole Derivatives, Pharmaceutical Compositions, And Methods Of Use
03/04/2010US20100056582 Modulators of LXR
03/04/2010US20100056579 Insecticidal n-substituted sulfoximines
03/04/2010US20100056578 Insecticidal n-substituted sulfoximines
03/04/2010US20100056574 Crystalline Forms of Sufentanil
03/04/2010US20100056567 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
03/04/2010US20100056541 Biphenyl compounds useful as muscarinic receptor antagonists
03/04/2010US20100056532 Compounds that modulate intracellular calcium
03/04/2010US20100056525 5- and 6- substituted benzimidazole thiophene compounds
03/04/2010US20100056521 (aza)indole derivative and use thereof for medical purposes
03/04/2010US20100056505 Substituted Pyrazalones
03/04/2010US20100055035 Bisaminoethanethiol-targeting ligand conjugates and compositions
03/04/2010CA2735730A1 2,4-diaminopyrimidine compound
03/04/2010CA2733648A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
03/03/2010EP2159223A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
03/03/2010EP2081572B1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
03/03/2010EP1957484B1 Glucagon receptor antagonists, preparation and therapeutic uses
03/03/2010EP1922316B1 Benzimidazole thiophene compounds as plk modulators
03/03/2010EP1753719B1 Substituted pyrrolidine-2-ones
03/03/2010EP1749001B1 3-piperidinylisochroman-5-ols as dopamine agonists
03/03/2010CN101659660A Preparation for biphenyl substituted 1,3,4-thia(oxa)diazole derivatives and use thereof as herbicide
03/03/2010CN101659639A Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/02/2010US7671088 Water-soluble etoposide analogs and methods of use thereof
03/02/2010US7671082 4-Amino-2,2-dioxo-2 lambda 6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester; glutamate receptor agonist; antidepressant, anxiolytic agent psychological, and psychiatric disorders; acylation amino compounds with amino acyl, deprotection
03/02/2010US7671076 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis
03/02/2010US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide
03/02/2010US7671056 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction
03/02/2010US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
02/2010
02/25/2010WO2010022125A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010022033A2 Therapeutic substituted pyrroles
02/25/2010WO2010021378A1 Dye-sensitized photovoltaic device
02/25/2010WO2010020522A1 Insecticidal compounds
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048664 Therapeutic substituted pyrroles
02/25/2010US20100048637 Cyclohexylamines, phenylamines and uses thereof
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/25/2010US20100048574 NOVEL HETEROCYCLIC NF-kB INHIBITORS
02/25/2010US20100048565 Benzimidazole derivatives
02/25/2010CA2734896A1 Therapeutic substituted pyrroles
02/25/2010CA2734487A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/24/2010EP2155735A2 Triazolyl aminopyrimidine compounds
02/24/2010EP2155734A2 Triazolyl aminopyrimidine compounds
02/24/2010EP2155733A1 Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure
02/24/2010EP2155722A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
02/24/2010EP2155720A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
02/24/2010EP2155716A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials